Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPE Volunteer Study of preoperative roxadustat-related gene expression
ACTRN12625000491460Phase 2Completed
- Sponsor
- Royal Perth Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of roxadustat in complications of surgical procedures and surgical site infection (SSI), sponsored by Royal Perth Hospital. Primary endpoint: Number of differentially expressed genes in whole blood. Started Jun 2025; status: completed.
02
Drugs
roxadustat
03
Conditions
complications of surgical proceduressurgical site infection (SSI)
Beyond the preview
Go deeper on ACTRN12625000491460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000491460.